by Advize Admin | Jun 16, 2023 | FWA, Healthcare
For those that remember Solaraze, it is one of the name brands for Diclofenac. Diclofenac is commonly known today as Voltaren. In 2018, the OIG conducted a study that reflected that there were some strong fraud indicators on the off-label use of Diclofenac (under...
by Advize Admin | Mar 10, 2023 | FWA
Leigh Fava wound up in the emergency room after injuring her thumb at her New Orleans home. She said she received a tetanus shot and a badly wrapped bandage — and an unexpectedly high bill. Her experiences trying to dispute the hospital’s charges left her feeling...
by Advize Admin | Mar 3, 2023 | Compliance, Providers
BUTTE, Mont. — Jennifer Mitchell remembered getting a call nearly two years ago that her 69-year-old husband, Bill, had crashed his car and had been committed to the Montana State Hospital, the state-run psychiatric hospital for adults about 20 miles from their home...
by Advize Admin | Feb 10, 2023 | Healthcare Facepalm, Technology
In early 2020, as they tried to fight covid-19 across two rural counties in North Carolina, the staff of Granville Vance Public Health was stymied, relying on outdated technology to track a fast-moving pandemic. Lisa Macon Harrison, the agency’s health...
by Advize Admin | Dec 2, 2022 | Compliance, FWA, Medical Record Auditing, OIG Files
When you first open this article, the most glaring of things is the time frame from which the audit was derived. 2011-2013 data is at this point so aged, the calculation of $1,000 per patient enrolled in a Medicare Advantage (MA) as the overcharged amount is simply...
Recent Comments